Literature DB >> 20935147

Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function.

Jennifer A Dixon1, William F Gaillard, William T Rivers, Christine N Koval, Robert E Stroud, Rupak Mukherjee, Francis G Spinale.   

Abstract

After a myocardial infarction (MI), an episode of ischemia-reperfusion (I/R) can result in a greater impairment of left ventricular (LV) regional function (LVRF) than that caused by an initial I/R episode in the absence of MI. Membrane type-I matrix metalloproteinase (MT1-MMP) proteolytically processes the myocardial matrix and is upregulated in LV failure. This study tested the central hypothesis that a differential induction of MT1-MMP occurs and is related to LVRF after I/R in the context of a previous MI. Pigs with a previous MI [3 wk postligation of the left circumflex artery (LCx)] or no MI were randomized to undergo I/R [60-min/120-min left anterior descending coronary artery (LAD) occlusion] or no I/R as follows: no MI and no I/R (n = 6), no MI and I/R (n = 8), MI and no I/R (n = 8), and MI and I/R (n = 8). Baseline LVRF (regional stroke work, sonomicrometry) was lower in the LAD region in the MI group compared with no MI (103 ± 12 vs. 188 ± 26 mmHg·mm, P < 0.05) and remained lower with peak ischemia (35 ± 8 vs. 88 ± 17 mmHg·mm, P < 0.05). Using a novel interstitial microdialysis method, MT1-MMP was directly measured and was over threefold higher in the LCx region and over twofold higher in the LAD region in the MI group compared with the no MI group at baseline. MT1-MMP fluorogenic activity was persistently elevated in the LCx region in the MI and I/R group but remained unchanged in the LAD region. In contrast, no changes in MT1-MMP occurred in the LCx region in the no MI and I/R group but increased in the LAD region. MT1-MMP mRNA was increased by over threefold in the MI region in the MI and I/R group. In conclusion, these findings demonstrate that a heterogeneous response in MT1-MMP activity likely contributes to regional dysfunction with I/R and that a subsequent episode of I/R activates a proteolytic cascade within the MI region that may contribute to a continued adverse remodeling process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935147      PMCID: PMC3006286          DOI: 10.1152/ajpheart.00314.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  50 in total

Review 1.  Latency, activation, and binding proteins of TGF-beta.

Authors:  K Koli; J Saharinen; M Hyytiäinen; C Penttinen; J Keski-Oja
Journal:  Microsc Res Tech       Date:  2001-02-15       Impact factor: 2.769

2.  Regional expression of endothelin-1, ANP, IGF-1, and LV wall stress in the infarcted rat heart.

Authors:  J P Loennechen; A Støylen; V Beisvag; U Wisløff; O Ellingsen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

Review 3.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

4.  Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction.

Authors:  Francis G Spinale; Rupak Mukherjee; Juozas A Zavadzkas; Christine N Koval; Shenikqua Bouges; Robert E Stroud; Lawrence W Dobrucki; Albert J Sinusas
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

5.  Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance.

Authors:  R S Keller; S Y Shai; C J Babbitt; C G Pham; R J Solaro; M L Valencik; J C Loftus; R S Ross
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

Authors:  I Yana; S J Weiss
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

7.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

8.  Myocardial infarct expansion and matrix metalloproteinase inhibition.

Authors:  Rupak Mukherjee; Theresa A Brinsa; Kathryn B Dowdy; Amelia A Scott; Julia M Baskin; Anne M Deschamps; Abigail S Lowry; G Patricia Escobar; David G Lucas; William M Yarbrough; Michael R Zile; Francis G Spinale
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

9.  Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs.

Authors:  William M Yarbrough; Rupak Mukherjee; Theresa A Brinsa; Kathryn B Dowdy; Amelia A Scott; G Patricia Escobar; Cassandra Joffs; David G Lucas; Fred A Crawford; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

10.  Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

Authors:  K Hotary; E Allen; A Punturieri; I Yana; S J Weiss
Journal:  J Cell Biol       Date:  2000-06-12       Impact factor: 10.539

View more
  7 in total

1.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

2.  Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling.

Authors:  Jeremy R McGarvey; Sara Pettaway; James A Shuman; Craig P Novack; Kia N Zellars; Parker D Freels; Randall L Echols; Jason A Burdick; Joseph H Gorman; Robert C Gorman; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2014-07-14       Impact factor: 4.030

3.  Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.

Authors:  Jennifer A Dixon; Robert C Gorman; Robert E Stroud; Rupak Mukherjee; Evan C Meyer; Nathaniel L Baker; Masato Morita; Hirotsugu Hamamoto; Liam P Ryan; Joseph H Gorman; Francis G Spinale
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

4.  Mechanistic relationship between membrane type-1 matrix metalloproteinase and the myocardial response to pressure overload.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An O Van Laer; Jeffrey A Jones; Risha Patel; Rupak Mukherjee; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2014-01-06       Impact factor: 8.790

Review 5.  Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors.

Authors:  Francis G Spinale; Francisco Villarreal
Journal:  Biochem Pharmacol       Date:  2014-04-26       Impact factor: 5.858

6.  Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.

Authors:  Shaina R Eckhouse; Adam W Akerman; Christina B Logdon; J Marshall Oelsen; Elizabeth C O'Quinn; Elizabeth K Nadeau; Robert E Stroud; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-25       Impact factor: 5.209

7.  Collagen denaturation in the infarcted myocardium involves temporally distinct effects of MT1-MMP-dependent proteolysis and mechanical tension.

Authors:  Anis Hanna; Arti V Shinde; Ruoshui Li; Linda Alex; Claudio Humeres; Prasanth Balasubramanian; Nikolaos G Frangogiannis
Journal:  Matrix Biol       Date:  2021-05-25       Impact factor: 10.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.